Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNYSE:HUM
Previous Symbol
CUSIP44485910
Phone502-580-1000
Debt
Debt-to-Equity Ratio0.45
Current Ratio1.68
Quick Ratio1.68
Price-To-Earnings
Trailing P/E Ratio26.26
Forward P/E Ratio21.30
P/E Growth1.45
Sales & Book Value
Annual Sales$53.77 billion
Price / Sales0.78
Cash Flow$15.3998 per share
Price / Cash Flow19.96
Book Value$68.89 per share
Price / Book4.46
Profitability
EPS (Most Recent Fiscal Year)$11.71
Net Income$2.45 billion
Net Margins2.70%
Return on Equity19.10%
Return on Assets6.36%
Miscellaneous
Employees45,900
Outstanding Shares137,190,000
Market Cap$41.98 billion
OptionableOptionable
Humana (NYSE:HUM) Frequently Asked Questions
What is Humana's stock symbol?
Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."
How often does Humana pay dividends? What is the dividend yield for Humana?
Humana announced a quarterly dividend on Friday, November 2nd. Investors of record on Monday, December 31st will be given a dividend of $0.50 per share on Friday, January 25th. This represents a $2.00 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date is Friday, December 28th. View Humana's Dividend History.
How will Humana's stock buyback program work?
Humana announced that its Board of Directors has approved a stock repurchase program on Friday, December 15th 2017, which authorizes the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.
How were Humana's earnings last quarter?
Humana Inc (NYSE:HUM) issued its quarterly earnings results on Wednesday, November, 7th. The insurance provider reported $4.58 earnings per share for the quarter, topping the consensus estimate of $4.29 by $0.29. The insurance provider had revenue of $14.21 billion for the quarter, compared to analyst estimates of $13.97 billion. Humana had a return on equity of 19.10% and a net margin of 2.70%. During the same period in the previous year, the firm earned $3.39 EPS. View Humana's Earnings History.
When is Humana's next earnings date?
What guidance has Humana issued on next quarter's earnings?
Humana updated its FY18 earnings guidance on Wednesday, November, 28th. The company provided EPS guidance of $14.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $14.43.
What price target have analysts set for HUM?
18 brokerages have issued twelve-month price targets for Humana's shares. Their forecasts range from $250.00 to $418.00. On average, they anticipate Humana's share price to reach $349.7778 in the next year. This suggests a possible upside of 13.8% from the stock's current price. View Analyst Price Targets for Humana.
What is the consensus analysts' recommendation for Humana?
18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 6 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.
Has Humana been receiving favorable news coverage?
Press coverage about HUM stock has trended somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Humana earned a coverage optimism score of 1.5 on InfoTrie's scale. They also assigned news articles about the insurance provider a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future.
Who are some of Humana's key competitors?
Who are Humana's key executives?
Humana's management team includes the folowing people:
- Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
- Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
- Mr. Christopher Mark Todoroff, Chief Legal Officer (Age 55)
- Mr. Timothy S. Huval, Chief HR Officer (Age 52)
- Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)
Who are Humana's major shareholders?
Humana's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (8.99%), BlackRock Inc. (8.94%), Vanguard Group Inc. (7.37%), Capital International Investors (5.99%), Capital Research Global Investors (2.86%) and Capital World Investors (2.45%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.
Which institutional investors are selling Humana stock?
HUM stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, MERIAN GLOBAL INVESTORS UK Ltd, Wells Fargo & Company MN, Mitsubishi UFJ Trust & Banking Corp, Alliancebernstein L.P., AQR Capital Management LLC, Point72 Asset Management L.P. and Ceredex Value Advisors LLC. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.
Which institutional investors are buying Humana stock?
HUM stock was bought by a variety of institutional investors in the last quarter, including Capital International Investors, Renaissance Technologies LLC, Ffcm LLC, Morgan Stanley, FMR LLC, Marshall Wace North America L.P., Vanguard Group Inc. and BlackRock Inc.. View Insider Buying and Selling for Humana.
How do I buy shares of Humana?
Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Humana's stock price today?
One share of HUM stock can currently be purchased for approximately $307.35.
How big of a company is Humana?
Humana has a market capitalization of $41.98 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.
What is Humana's official website?
How can I contact Humana?
Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.
MarketBeat Community Rating for Humana (NYSE HUM)
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
